Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health.
暂无分享,去创建一个
Vasken Dilsizian | Heinrich R Schelbert | V. Dilsizian | H. Schelbert | A. Quercioli | Thomas H Schindler | T. Schindler | Alessandra Quercioli
[1] P. Ganz,et al. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. , 2003, Circulation.
[2] D. Berman,et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[3] K. Gould,et al. Does coronary flow trump coronary anatomy? , 2009, JACC. Cardiovascular imaging.
[4] M. Nieminen,et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. , 2006, The American journal of cardiology.
[5] M. Phelps,et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] V. Dilsizian,et al. PET myocardial perfusion and metabolism clinical imaging , 2009 .
[7] John O. Prior,et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. , 2006, Journal of the American College of Cardiology.
[8] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[9] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[10] Michael E. Phelps,et al. PET: Molecular Imaging and Its Biological Applications , 2004 .
[11] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[12] D E Kuhl,et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. , 1991, The American journal of cardiology.
[13] J. Yap,et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] M. Phelps,et al. Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve , 1993, Circulation.
[15] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[16] G. Fakhri,et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[17] V. Dilsizian,et al. Nuclear Cardiac Stress Testing in the Era of Molecular Medicine* , 2008, Journal of Nuclear Medicine.
[18] O. Rimoldi,et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] P. Camici. Absolute figures are better than percentages. , 2009, JACC. Cardiovascular imaging.
[20] John O. Prior,et al. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Marcelo F. Di Carli,et al. Advances in positron emission tomography , 2004 .
[22] ThomasMünzel,et al. Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase , 2005 .
[23] P. Kaufmann,et al. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. , 2000, Journal of the American College of Cardiology.
[24] W. Smith,et al. Quantitative gated single photon emission computed tomography imaging: A counts-based method for display and measurement of regional and global ventricular systolic function , 1997, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[25] H. Schelbert,et al. Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus. , 2009, European heart journal.
[26] John O. Prior,et al. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] O Muzik,et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] G. Hutchins,et al. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[29] R. Kwong,et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. , 2009, JACC. Cardiovascular imaging.
[30] H. Schelbert,et al. L-Arginine normalizes coronary vasomotion in long-term smokers. , 1999, Circulation.
[31] Georges El Fakhri,et al. Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.
[32] N. Mullani,et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. , 1989, Circulation.
[33] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[34] Filippo Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[35] M. Phelps,et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] V. Fuster,et al. Disease Prevention: The moving target of global cardiovascular health , 2009, Nature Reviews Cardiology.
[37] H. Schelbert,et al. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. , 1996, Circulation.
[38] Ran Klein,et al. Quantification of myocardial blood flow with 82Rb dynamic PET imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[39] Uchechukwu Sampson,et al. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] John O. Prior,et al. Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. , 2008, European heart journal.
[41] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[42] O. Rimoldi,et al. The Clinical Value of Myocardial Blood Flow Measurement* , 2009, Journal of Nuclear Medicine.
[43] H. Schelbert,et al. Positron Emission Tomography of the Heart: Methodology, Findings in the Normal and the Diseased Heart, and Clinical Applications , 2004 .
[44] Pascal Meier,et al. Beneficial Effect of Recruitable Collaterals: A 10-Year Follow-Up Study in Patients With Stable Coronary Artery Disease Undergoing Quantitative Collateral Measurements , 2007, Circulation.
[45] F. Coppi,et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.
[46] Oliver Gaemperli,et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.
[47] S S Gambhir,et al. Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.
[48] V. Treyer,et al. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: Validation of a new fast factor analysis , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[49] K. Gould,et al. Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution. , 2009, JACC. Cardiovascular imaging.
[50] H. Schelbert. Quantifying Myocardial Perfusion for the Assessment of Preclinical CAD , 2007 .
[51] C J Slager,et al. Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. , 1995, Circulation.
[52] Stephen L. Bacharach,et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[53] H. Schelbert,et al. Noninvasive Assessment of Coronary Microcirculatory Function in Postmenopausal Women and Effects of Short-Term and Long-Term Estrogen Administration , 2002, Circulation.
[54] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[55] D. Berman,et al. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. , 2004, Journal of the American College of Cardiology.
[56] John O. Prior,et al. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[57] J. Hodgson,et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.
[58] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[59] S. Daniels,et al. America's children: a critical time for prevention. , 2005, Circulation.
[60] W J MacIntyre,et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[61] Bernd J Pichler,et al. Latest Advances in Molecular Imaging Instrumentation , 2008, Journal of Nuclear Medicine.
[62] L. Deckelbaum,et al. Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group. , 1997, Circulation.
[63] John O. Prior,et al. Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus , 2005, Circulation.
[64] S. Nekolla,et al. Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model , 2009, Circulation.
[65] Raymond Kwong,et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. , 2007, Journal of the American College of Cardiology.
[66] Georges El Fakhri,et al. Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[67] J. Knuuti,et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas™) , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[68] W. Burchert,et al. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[69] John D Friedman,et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[70] A. Fischman,et al. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. , 2009, JACC. Cardiovascular imaging.
[71] D. Berman,et al. Prognostic Implications of Myocardial Perfusion Single-Photon Emission Computed Tomography in the Elderly , 2009, Circulation.
[72] P. Camici,et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. , 1994, The New England journal of medicine.
[73] Keiichiro Yoshinaga,et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? , 2006, Journal of the American College of Cardiology.
[74] John O. Prior,et al. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes , 2006, Heart.
[75] O Muzik,et al. Assessment of myocardial perfusion by positron emission tomography. , 1991, The American journal of cardiology.
[76] B. Chow,et al. Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. , 2006, Journal of the American College of Cardiology.
[77] S. Achenbach,et al. The year in coronary artery disease. , 2009, JACC. Cardiovascular imaging.
[78] Cyrill Burger,et al. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[79] Takahiro Higuchi,et al. Cardiac positron emission tomography. , 2009, Journal of the American College of Cardiology.
[80] Gram Jb,et al. The Scandinavian Simvastatin Survival Study (4S) , 1995 .
[81] U. Gleichmann,et al. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. , 1999, Circulation.
[82] G. Beller,et al. Decision making in multivessel coronary disease: the need for physiological lesion assessment. , 2010, JACC. Cardiovascular interventions.
[83] M J Welch,et al. Quantification of regional myocardial blood flow in vivo with H2150* , 2005 .
[84] Gerald M. Pohost,et al. Cardiac CT, PET and MR , 2006 .
[85] V. Dilsizian,et al. PET Assessment of Myocardial Perfusion , 2010 .
[86] A. Zeiher,et al. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome , 2004, Coronary artery disease.
[87] Marcelo F. Di Carli,et al. Cardiac PET and PET/CT imaging / , 2007 .
[88] H. Schelbert,et al. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. , 1996, Journal of the American College of Cardiology.
[89] Ran Klein,et al. Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-From basic aspects to clinical applications. , 2010, Journal of cardiology.
[90] A F Laine,et al. Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[91] M. Lauer,et al. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. , 1997, The American journal of cardiology.
[92] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[93] Hans L Hillege,et al. Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease , 2009, Journal of Nuclear Medicine.
[94] S. Nekolla,et al. Evaluation of a Novel 18F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats , 2009, Circulation. Cardiovascular imaging.
[95] R. Hawkins,et al. Advances in positron emission tomography imaging for the GI tract. , 2002, Gastrointestinal endoscopy.
[96] William Wijns,et al. Relation Between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis , 1995 .
[97] Adriaan A. Lammertsma,et al. Noninvasive Quantification of Regional Myocardial Blood Flow in Coronary Artery Disease With Oxygen‐15–Labeled Carbon Dioxide Inhalation and Positron Emission Tomography , 1991, Circulation.
[98] G. Beller,et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. , 2003, Journal of the American College of Cardiology.
[99] Juhani Knuuti,et al. Quantification of myocardial blood flow will reform the detection of CAD , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[100] N. Tamaki,et al. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. , 2007, Journal of the American College of Cardiology.
[101] A. Luxen,et al. Direct Comparison of [13N]Ammonia and [150]Water Estimates of Perfusion With Quantification of Regional Myocardial Blood Flow by Microspheres , 1993, Circulation.
[102] Robert Elashoff,et al. Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals , 2004, Annals of Internal Medicine.
[103] Osamu Manabe,et al. Repeatability of Rest and Hyperemic Myocardial Blood Flow Measurements with 82Rb Dynamic PET , 2008, Journal of Nuclear Medicine.
[104] Hatem Alkadhi,et al. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[105] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[106] Erland Erdmann,et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.
[107] S. Achenbach,et al. Coronary Multidetector Computed Tomography in the Assessment of Patients With Acute Chest Pain , 2006, Circulation.
[108] G. Beller. Underestimation of coronary artery disease with SPECT perfusion imaging , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[109] A. Takahashi,et al. Quantitative Measures of Coronary Stenosis Severity by 64-Slice CT Angiography and Relation to Physiologic Significance of Perfusion in Nonobese Patients: Comparison with Stress Myocardial Perfusion Imaging , 2008, Journal of Nuclear Medicine.
[110] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[111] N. Tamaki,et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[112] I. Olivotto,et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[113] D. Neglia,et al. Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.
[114] Michael Kreissl,et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. , 2005, Journal of the American College of Cardiology.
[115] John O. Prior,et al. Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors , 2004, Circulation.
[116] W. Wijns,et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. , 2010, JACC. Cardiovascular interventions.
[117] E. Hoffman,et al. Validation of PET-acquired input functions for cardiac studies. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[118] M E Phelps,et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. , 1995, Circulation.
[119] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[120] P. Marraccini,et al. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. , 1993, Journal of the American College of Cardiology.
[121] R. Karas,et al. HRT and the young at heart. , 2007, The New England journal of medicine.
[122] Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.
[123] D. Berman,et al. Cardiovascular imaging research at the crossroads. , 2010, JACC. Cardiovascular imaging.
[124] M. Phelps,et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. , 1995, Circulation.
[125] H. Schelbert,et al. Role of PET in the evaluation and understanding of coronary physiology , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[126] H. Schelbert,et al. Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.